Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeAbbVie

      AbbVie

      AbbVie Boosts 2027 Sales Forecast for Immunology Drugs 
      Investing News

      AbbVie Boosts 2027 Sales Forecast for Immunology Drugs 

      February 2, 2024
      AbbVie Boosts Profit Outlook as Humira Maintains Strength
      Investing News

      AbbVie Boosts Profit Outlook as Humira Maintains Strength

      July 27, 2023
      Is AbbVie Stock A Buy Now That Share Prices Have Dropped?
      Trading Tips

      Is AbbVie Stock A Buy Now That Share Prices Have Dropped?

      February 6, 2023
      Abbvie Stock Price Rose After the Company and Lilly Pulled Out of a Medicine Pricing Agreement in the UK
      Investing News

      Abbvie Stock Price Rose After the Company and Lilly Pulled Out of a Medicine Pricing Agreement in the UK

      January 16, 2023
      AbbVie stock up in wake of partnership with Immunome 
      Investing News

      AbbVie stock up in wake of partnership with Immunome 

      January 6, 2023
      This Week’s Stocks to Avoid
      Investing News

      This Week’s Stocks to Avoid

      October 25, 2022
      Abbvie Stock Recovers Some of Its Previous Losses When Svb Leerink Retracts Some of Its Guiding Statements.
      Investing News

      Abbvie Stock Recovers Some of Its Previous Losses When Svb Leerink Retracts Some of Its Guiding Statements.

      September 30, 2022
      AbbVie Stock Valuation Is Appealing Due to Humira Challenges
      Trading Tips

      AbbVie Stock Valuation Is Appealing Due to Humira Challenges

      September 19, 2022
      AbbVie’s Botox Could Lose Market Share To Revance New Drug After FDA Approval
      Investing News

      AbbVie’s Botox Could Lose Market Share To Revance New Drug After FDA Approval

      September 8, 2022

       

      LATEST NEWS

      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview
      • Investing News Okta’s Strong Q3 2026 Earnings Boost Shares
      • Investing News American Eagle Q3 2025 Earnings Report

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025